Background and objective Continuous positive airway pressure (CPAP) is the first‐line
therapy for obstructive sleep apnoea (OSA). Residual apnoea and/or hypopnoea events …

Randomised controlled trials (RCTs) of continuous positive airway pressure (CPAP) in
obstructive sleep apnoea (OSA) are time consuming, and their findings often inconclusive or …

ABSTRACT CPAP is considered the gold standard treatment in OSA and is highly
efficacious in controlling OSA symptoms. However, treatment effectiveness is limited …

Continuous positive airway pressure (CPAP) is the treatment of choice for obstructive sleep
apnoea (OSA), but compliance and variables involved in long-term CPAP adherence in …

The percentage of compliant continuous positive airway pressure (CPAP)-treated apnoeic
patients that continue to experience residual excessive sleepiness (RES) is unknown. RES …

Objective Excessive daytime sleepiness (EDS) persists in some patients with obstructive
sleep apnea (OSA) despite continuous positive airway pressure (CPAP) treatment. This …

We evaluated factors associated with subjective and objective sleepiness at baseline and
after 6 months of continuous positive airway pressure (CPAP) therapy in patients with …

Background Long-term continuous positive airway pressure (CPAP) usage varies between
individuals. It would be of value to be able to identify those who are likely to benefit from …

Introduction Continuous positive airway pressure (CPAP) is currently the treatment of choice
for sleepiness in patients with obstructive sleep apnoea (OSA); however, adherence is often …

Background and objective Continuous positive airway pressure (CPAP) is the most common
treatment for obstructive sleep apnoea (OSA), but many patients fail long‐term therapy …